Headquartered in Santa Clara, CA Fiscal year ends October NYSE: A agilent.com
Agilent Technologies, Inc. (NYSE: A) is a global provider of analytical and clinical laboratory technologies, delivering instruments, software, services, and expertise across life sciences, diagnostics, and applied chemistry markets. The company operates through three segments: Life Sciences and Diagnostics Markets Group (LDG), which serves pharmaceutical, biotech, clinical, and academic research customers; Agilent CrossLab Group (ACG), which provides laboratory services, consumables, and enterprise informatics solutions; and Applied Markets Group (AMG), which serves food safety, environmental, forensics, and chemical analysis markets. Agilent generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide. The company's Ignite Operating System drives operational efficiency and margin expansion across its businesses. Updated
Agilent Technologies has a company-confirmed earnings report dropping after the close on August 26, and every operating lever heading into that date is pointing the same direction. Here is what retirement-focused investors…
Pre-Market Stock Futures: Futures are trading lower on Thursday as new records are set almost daily, with the AI/Data center trade continuing to push stocks higher on Wednesday. All four major indices…
Pre-Market Stock Futures: Futures are trading higher as we hit the mid-week point, as the technology-led rally continues to spiral higher. While the major indices finished the day mixed, the technology-heavy Nasdaq…
U.S. equity benchmarks remain richly valued, and a growing chorus of strategists is reminding retail investors that single-country exposure has historically been a portfolio risk. For investors scanning for non-U.S. revenue streams…
Citi swept through its life science tools and diagnostics coverage on Wednesday, opening a 90-day upside catalyst watch on Agilent Technologies (NYSE:A | A Price Prediction) while trimming its price target on…
Pre-Market Stock Futures: Futures are trading dramatically lower as we start the holiday-shortened trading week, following yesterday’s MLK remembrance day. The futures downdraft this morning is being attributed to President Trump’s threat…
Pre-Market Stock Futures: The futures are trading flat on Tuesday after we opened the week on the downside, with all major indices finishing the day lower. With the Federal Reserve meeting this…
Here is an assessment of how safe the dividend at Abbott Laboratories appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Friday's top analyst upgrades and downgrades included Agilent, Boeing, General Electric, Lockheed Martin, Meta Platforms, Micron Technology, Redfin, Salesforce, Trade Desk, Unity Software and Workday.
Thursday's additional top analyst upgrades and downgrades were on Agilent Technologies, KB Home, Kosmos Energy, Lennar, Snowflake, Thermo Fisher Scientific and more.
Citigroup is moving to the sidelines on a few stocks after they reported their most recent quarterly results.
Thurs day's top analyst upgrades and downgrades included Ally Financial, APA, Caesars Entertainment, Chevron, Danaher, Datadog, EOG Resources, EQT, Harley-Davidson, Las Vegas Sands, Netflix, Pioneer Natural Resources, Rio Tinto, Twilio, VICI Properties…
Friday's top analyst upgrades and downgrades included Agilent Technologies, Bunge, Duolingo, Dynatrace, Emerson Electric, Kohl’s, Lamar Advertising, Oshkosh, Regions Financial, Splunk, Spotify, XPO Logistics and more.
Thursday's top analyst upgrades and downgrades included Agilent Technologies, Apple, Best Buy, Coinbase Global, CrowdStrike, Equitable, Intuit, Lululemon Athletica, Okta, Petco Health and Wellness, Porch, Sabra Health Care REIT, Teladoc Health, Toast…
Monday’s additional top analyst upgrades and downgrades included Agilent Technologies, Barrick Gold, Deere, Kellogg, Marathon Oil, Newmont, Penn National Gaming, Spotify Technology and Verizon Communications.
Agilent Technologies, Inc. (NYSE: A) is a global provider of analytical and clinical laboratory technologies, delivering instruments, software, services, and expertise across life sciences, diagnostics, and applied chemistry markets.
24/7 Wall St.'s 12-month price target for A is $198.77, rated Buy. The Wall Street consensus target is $178.00. A price prediction →
